Rees Scientific continues to be impressed with the work put in by our clients. NIH, a Rees Scientific customer, recently announced the COVID-19 vaccine candidate developed with Moderna has advanced to a Phase 3 clinical trial, after showing promising results in Phase 1 and 2.
Learn more about this advancement.
This post is related to:
Personalized Wellness, Point-of-Care Services Temperature Monitoring (Wireless)